These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 28518060)
21. Genome-wide methylation analysis of tubulocystic and papillary renal cell carcinomas. Korabecna M; Geryk J; Hora M; Steiner P; Seda O; Tesar V Neoplasma; 2016; 63(3):402-10. PubMed ID: 26925785 [TBL] [Abstract][Full Text] [Related]
22. Genetic and epigenetic alterations during renal carcinogenesis. Arai E; Kanai Y Int J Clin Exp Pathol; 2010 Dec; 4(1):58-73. PubMed ID: 21228928 [TBL] [Abstract][Full Text] [Related]
23. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Morris MR; Ricketts CJ; Gentle D; McRonald F; Carli N; Khalili H; Brown M; Kishida T; Yao M; Banks RE; Clarke N; Latif F; Maher ER Oncogene; 2011 Mar; 30(12):1390-401. PubMed ID: 21132003 [TBL] [Abstract][Full Text] [Related]
25. Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma. Andersson-Evelönn E; Vidman L; Källberg D; Landfors M; Liu X; Ljungberg B; Hultdin M; Rydén P; Degerman S J Transl Med; 2020 Nov; 18(1):435. PubMed ID: 33187526 [TBL] [Abstract][Full Text] [Related]
26. Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma. Wang J; Zhang Q; Zhu Q; Liu C; Nan X; Wang F; Fang L; Liu J; Xie C; Fu S; Song B J Cell Physiol; 2020 Feb; 235(2):1296-1308. PubMed ID: 31273792 [TBL] [Abstract][Full Text] [Related]
27. Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer. Stewart GD; Powles T; Van Neste C; Meynert A; O'Mahony F; Laird A; Deforce D; Van Nieuwerburgh F; Trooskens G; Van Criekinge W; De Meyer T; Harrison DJ Oncotarget; 2016 May; 7(18):25241-50. PubMed ID: 27029034 [TBL] [Abstract][Full Text] [Related]
28. Methylation pattern of the putative tumor-suppressor gene LRRC3B promoter in clear cell renal cell carcinomas. Kondratov AG; Stoliar LA; Kvasha SM; Gordiyuk VV; Zgonnyk YM; Gerashchenko AV; Vozianov AF; Rynditch AV; Zabarovsky ER; Kashuba VI Mol Med Rep; 2012 Feb; 5(2):509-12. PubMed ID: 22101383 [TBL] [Abstract][Full Text] [Related]
29. Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma. Tang W; Cao Y; Ma X Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633782 [TBL] [Abstract][Full Text] [Related]
30. Identification of novel epigenetic markers for clear cell renal cell carcinoma. Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284 [TBL] [Abstract][Full Text] [Related]
31. DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients. Peters I; Dubrowinskaja N; Hennenlotter J; Antonopoulos WI; Von Klot CAJ; Tezval H; Stenzl A; Kuczyk MA; Serth J Oncol Rep; 2018 Dec; 40(6):3861-3868. PubMed ID: 30272321 [TBL] [Abstract][Full Text] [Related]
33. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Ibanez de Caceres I; Dulaimi E; Hoffman AM; Al-Saleem T; Uzzo RG; Cairns P Cancer Res; 2006 May; 66(10):5021-8. PubMed ID: 16707423 [TBL] [Abstract][Full Text] [Related]
34. Epigenetic silencing of Na,K-ATPase β 1 subunit gene ATP1B1 by methylation in clear cell renal cell carcinoma. Selvakumar P; Owens TA; David JM; Petrelli NJ; Christensen BC; Lakshmikuttyamma A; Rajasekaran AK Epigenetics; 2014 Apr; 9(4):579-86. PubMed ID: 24452105 [TBL] [Abstract][Full Text] [Related]
35. Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer. Christoph F; Kempkensteffen C; Weikert S; Köllermann J; Krause H; Miller K; Schostak M; Schrader M Br J Cancer; 2006 Dec; 95(12):1701-7. PubMed ID: 17133271 [TBL] [Abstract][Full Text] [Related]
36. Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma. Fabrizio FP; Costantini M; Copetti M; la Torre A; Sparaneo A; Fontana A; Poeta L; Gallucci M; Sentinelli S; Graziano P; Parente P; Pompeo V; De Salvo L; Simone G; Papalia R; Picardo F; Balsamo T; Flammia GP; Trombetta D; Pantalone A; Kok K; Paranita F; Muscarella LA; Fazio VM Oncotarget; 2017 Feb; 8(7):11187-11198. PubMed ID: 28061437 [TBL] [Abstract][Full Text] [Related]
37. Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer. El Khoury LY; Fu S; Hlady RA; Wagner RT; Wang L; Eckel-Passow JE; Castle EP; Stanton ML; Thompson RH; Parker AS; Ho TH; Robertson KD Clin Epigenetics; 2021 Jan; 13(1):12. PubMed ID: 33461589 [TBL] [Abstract][Full Text] [Related]
38. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma. Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749 [TBL] [Abstract][Full Text] [Related]
39. Consequences of VHL Loss on Global DNA Methylome. Robinson CM; Lefebvre F; Poon BP; Bousard A; Fan X; Lathrop M; Tost J; Kim WY; Riazalhosseini Y; Ohh M Sci Rep; 2018 Feb; 8(1):3313. PubMed ID: 29463811 [TBL] [Abstract][Full Text] [Related]
40. Discrete Versions of Jensen-Fisher, Fisher and Bayes-Fisher Information Measures of Finite Mixture Distributions. Kharazmi O; Balakrishnan N Entropy (Basel); 2021 Mar; 23(3):. PubMed ID: 33803766 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]